rs76929858

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_001112741.2(KCNC1):​c.72G>A​(p.Ser24Ser) variant causes a synonymous change. The variant allele was found at a frequency of 0.00541 in 1,601,310 control chromosomes in the GnomAD database, including 408 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.029 ( 215 hom., cov: 32)
Exomes 𝑓: 0.0030 ( 193 hom. )

Consequence

KCNC1
NM_001112741.2 synonymous

Scores

1
1

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 3.90

Publications

1 publications found
Variant links:
Genes affected
KCNC1 (HGNC:6233): (potassium voltage-gated channel subfamily C member 1) This gene encodes a member of a family of integral membrane proteins that mediate the voltage-dependent potassium ion permeability of excitable membranes. Alternative splicing is thought to result in two transcript variants encoding isoforms that differ at their C-termini. These isoforms have had conflicting names in the literature: the longer isoform has been called both "b" and "alpha", while the shorter isoform has been called both "a" and "beta" (PMIDs 1432046, 12091563). [provided by RefSeq, Oct 2014]
KCNC1 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
  • progressive myoclonic epilepsy type 7
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
  • progressive myoclonus epilepsy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 11-17736074-G-A is Benign according to our data. Variant chr11-17736074-G-A is described in ClinVar as Benign. ClinVar VariationId is 447617.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0962 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNC1NM_001112741.2 linkc.72G>A p.Ser24Ser synonymous_variant Exon 1 of 4 ENST00000265969.8 NP_001106212.1
KCNC1NM_004976.4 linkc.72G>A p.Ser24Ser synonymous_variant Exon 1 of 2 NP_004967.1
KCNC1XM_047426916.1 linkc.72G>A p.Ser24Ser synonymous_variant Exon 1 of 4 XP_047282872.1
KCNC1XR_930866.3 linkn.1294G>A non_coding_transcript_exon_variant Exon 1 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNC1ENST00000265969.8 linkc.72G>A p.Ser24Ser synonymous_variant Exon 1 of 4 5 NM_001112741.2 ENSP00000265969.7

Frequencies

GnomAD3 genomes
AF:
0.0286
AC:
4345
AN:
152158
Hom.:
216
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0989
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0103
Gnomad ASJ
AF:
0.00260
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000413
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00637
Gnomad NFE
AF:
0.000500
Gnomad OTH
AF:
0.0201
GnomAD2 exomes
AF:
0.00779
AC:
1799
AN:
230924
AF XY:
0.00559
show subpopulations
Gnomad AFR exome
AF:
0.108
Gnomad AMR exome
AF:
0.00461
Gnomad ASJ exome
AF:
0.00290
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000352
Gnomad OTH exome
AF:
0.00298
GnomAD4 exome
AF:
0.00298
AC:
4313
AN:
1449034
Hom.:
193
Cov.:
32
AF XY:
0.00252
AC XY:
1813
AN XY:
719758
show subpopulations
African (AFR)
AF:
0.103
AC:
3420
AN:
33150
American (AMR)
AF:
0.00518
AC:
227
AN:
43814
Ashkenazi Jewish (ASJ)
AF:
0.00277
AC:
71
AN:
25610
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39226
South Asian (SAS)
AF:
0.000213
AC:
18
AN:
84516
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51062
Middle Eastern (MID)
AF:
0.00488
AC:
28
AN:
5738
European-Non Finnish (NFE)
AF:
0.000171
AC:
189
AN:
1106112
Other (OTH)
AF:
0.00602
AC:
360
AN:
59806
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
228
457
685
914
1142
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0286
AC:
4348
AN:
152276
Hom.:
215
Cov.:
32
AF XY:
0.0276
AC XY:
2056
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.0987
AC:
4101
AN:
41560
American (AMR)
AF:
0.0103
AC:
158
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00260
AC:
9
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5148
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00685
AC:
2
AN:
292
European-Non Finnish (NFE)
AF:
0.000500
AC:
34
AN:
68014
Other (OTH)
AF:
0.0199
AC:
42
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
201
402
604
805
1006
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00870
Hom.:
16
Bravo
AF:
0.0326
Asia WGS
AF:
0.00491
AC:
18
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 31, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jun 11, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jan 08, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Progressive myoclonic epilepsy type 7 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.43
CADD
Benign
14
DANN
Uncertain
0.98
PhyloP100
3.9
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76929858; hg19: chr11-17757621; API